Innovative NHE3 Inhibitor Advances Visceral Pain Treatment Industry Trends Gaining Momentum in the Global Visceral Pain Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

Visceral Pain Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for visceral pain has seen a significant rise in the past few years. The prediction is that it will increase from $13.84 billion in 2024 to $14.87 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The upward trajectory during the historic period is credited to factors such as the aging population, spike in the occurrence of chronic diseases, progress in medical research, development of the healthcare infrastructure, and a rise in awareness and diagnosis rates.

Visceral Pain Market Size Forecast: What's the Projected Valuation by 2029?
Over the next few years, we can anticipate a strong expansion in the size of the visceral pain market. Its growth trajectory is projected to reach $18.71 billion by 2029, with a compound annual growth rate (CAGR) of 5.9%. Factors contributing to this projected growth during the forecast period includes advances in pain management technology, the rising demand for non-invasive treatment methods, expanding markets and untapped potentials, approaches to personalized medicine, and the incorporation of digital health solutions. The forecast period is expected to witness several major trends like the shift towards multimodal pain management, increased focus on alternative therapies, advancement of targeted therapies for specific types of pain, the expanding impact of telemedicine on pain management, and the incorporation of artificial intelligence in assessing pain.

View the full report here:
https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report

What Are the Drivers Transforming the Visceral Pain Market?
An increased need for pain relieving medications, referred to as analgesics, is projected to propel the expansion of the visceral pain market in the future. Analgesics work by reducing or inhibiting the sensation of pain signals in the brain, thus helping to treat visceral pain which affects the nervous system and modifies pain signals from internal organs. An example is seen in April 2024 where, according to the New England Journal of Medicine, a weekly medical journal based in the UK, the number of doctors prescribing buprenorphine had risen to over 53,600 by December 2023. This signifies an upsurge of 11,500 prescribers compared to December 2022. Hence, it is this growing demand for analgesics which is propelling the enlargement of the visceral pain market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13950&type=smp

What Long-Term Trends Will Define the Future of the Visceral Pain Market?
Leading corporations in the visceral pain market are striving to create cutting-edge products such as NHE3 Inhibitors to deliver trustworthy services to their clients. This type of medication functions by suppressing the Sodium-Proton-Exchanger subtype 3 (NHE3) in the intestine. In April 2022, for example, Ardelyx, an American biopharmaceutical firm, introduced a new drug, IBSRELA, which is an NHE3 Inhibitor. IBSRELA is a breakthrough treatment intended for adults suffering from irritable bowel syndrome accompanied by constipation (IBS-C), and it functions by restricting the Sodium-Hydrogen Exchanger 3 (NHE3) activity in the small intestine and colon. It has demonstrated its capacity to alleviate abdominal discomfort by reducing visceral hypersensitivity and intestinal permeability, according to animal studies.

Which Segments in the Visceral Pain Market Offer the Most Profit Potential?
The visceral pain market covered in this report is segmented -

1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes
2) By Indications: Interstitial Cystitis, Crohn's, Irritable Bowel, Chronic Prostatitis, Other Indications
3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:
1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAID): Selective COX-2 Inhibitors, Non-Selective NSAIDs
3) By Other Drug Classes: Opioids, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13950&type=smp

Which Firms Dominate the Visceral Pain Market by Market Share and Revenue in 2025?
Major companies operating in the visceral pain market report are Walgreens Boots Alliance Inc., Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.

Which Regions Offer the Highest Growth Potential in the Visceral Pain Market?
North America was the largest region in the visceral pain market in 2024. The regions covered in the visceral pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13950

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.